# Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

> **NCT02021292** · PHASE2 · COMPLETED · sponsor: **Actelion** · enrollment: 80 (actual)

## Conditions studied

- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **DRUG:** Macitentan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02021292
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-20
- **Primary completion:** 2016-09-28
- **Final completion:** 2016-09-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021292, "Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02021292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*